GET THE APP

Responses to well-known genotoxic agents in germ stem cells in vi | 31013
Journal of Cell Science & Therapy

Journal of Cell Science & Therapy
Open Access

ISSN: 2157-7013

+44 1300 500008

Responses to well-known genotoxic agents in germ stem cells in vitro


6th World Congress on Cell & Stem Cell Research

February 29-March 02, 2016 Philadelphia, USA

DianaAnderson, K Habas, M Najafzadeh, A Baumgartner and M H Brinkworth

University of Bradford, UK

Scientific Tracks Abstracts: J Cell Sci Ther

Abstract :

Germline stem cells are extremely sensitive to genotoxic chemotherapeutic agentswhich induce DNA damage, and even low doses to the testis may pose reproductive risks with potential treatment-related infertility. Strand breaks represent a great threat to the genomic integrity of spermatogonial stem cells, which are essential to maintain spermatogenesis and prevent reproduction failure. The single-cell gel electrophoresis (Comet) assay has been used to measure DNA damage in male germ cells. We investigated the effects in vitro, of six well-known genotoxins on rat germ stem cells separated using STA-PUT unit-gravity velocity sedimentation. N-ethyl- N-nitrosourea (ENU), N-methyl-N-nitrosourea (MNU), 6-mercaptopurine and 5-bromodeoxyuridine, methyl methanesulfonate (MMS) and ethyl methanesulfonate (EMS) are potent male rodent germ cell mutagens. All compounds were significantly genotoxic in cultured germ cells. Treatment of the isolated germ cells with ENU and MNU produced a concentration-related increase in DNA damage in spermatogonia;spermatocytes were most sensitive to 6-MP and 5-brdU with MMS and EMS most damaging in spermatids. Immunocytochemistry and western blot analysis revealed that the purities of the isolated germ cells were 90% with viability over 95%. These results indicate that STA-PUT isolated rat testicular germ cells are a suitable model to study the genotoxicity of individual chemicals in germ stem cells and could be used as a surrogate system for humans. Only sperm can be examined in this way in humans.

Biography :

Diana Anderson completed her PhD at the University ofManchester, UK in the Faculty of Medicine. She is the Established Chair in Biomedical Sciences at the University of Bradford. She has published more than 450 papers, 8 books, successfully supervised 30 PhD students, and has a Hirsch index of 58. She is Editor –in- Chief of a Book Series for the Royal Society of Chemistry and is a Consultant to many International Organisations, such as the World Health Organisation/ International Programme of Chemical Safety.

Email: D.Anderson1@bradford.ac.uk

Top